Abstract
Chemoradiation-resistant cancers limit treatment efficacy and safety. We show here the cancer cell–specific, on-demand intracellular amplification of chemotherapy and chemoradiation therapy via gold nanoparticle– and laser pulse–induced mechanical intracellular impact. Cancer aggressiveness promotes the clustering of drug nanocarriers and gold nanoparticles in cancer cells. This cluster, upon exposure to a laser pulse, generates a plasmonic nanobubble, the mechanical explosion that destroys the host cancer cell or ejects the drug into its cytoplasm by disrupting the liposome and endosome. The same cluster locally amplifies external X-rays. Intracellular synergy of the mechanical impact of plasmonic nanobubble, ejected drug and amplified X-rays improves the efficacy of standard chemoradiation in resistant and aggressive head and neck cancer by 100-fold in vitro and 17-fold in vivo, reduces the effective entry doses of drugs and X-rays to 2–6% of their clinical doses and efficiently spares normal cells. The developed quadrapeutics technology combines four clinically validated components and transforms a standard macrotherapy into an intracellular on-demand theranostic microtreatment with radically amplified therapeutic efficacy and specificity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
18 November 2014
In the version of this article initially published, the sentence “At the same time, standard photoacoustic imaging of the same animals failed to detect MRD (Supplementary Fig. 5d)” was incorrect. It should have read “At the same time, standard photoacoustic imaging of the same animals was unable to detect even the large primary tumor (Supplementary Fig. 5d).” The error has been corrected in the HTML and PDF versions of the article.
References
Meier, J.D., Oliver, D.A. & Varvares, M.A. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck 27, 952–958 (2005).
Langendijk, J.A. et al. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J. Clin. Oncol. 26, 3770–3776 (2008).
Libutti, S.K. et al. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin. Cancer Res. 16, 6139–6149 (2010).
Kean, W.F. & Kean, I.R. Clinical pharmacology of gold. Inflammopharmacology 16, 112–125 (2008).
Sharafinski, M.E., Ferris, R.L., Ferrone, S. & Grandis, J.R. Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck. Head Neck 32, 1412–1421 (2010).
Iakoubov, L., Rokhlin, O. & Torchilin, V. Anti-nuclear autoantibodies of the aged reactive against the surface of tumor but not normal cells. Immunol. Lett. 47, 147–149 (1995).
Lukianova-Hleb, E. et al. Plasmonic nanobubbles as transient vapor nanobubbles generated around plasmonic nanoparticles. ACS Nano 4, 2109–2123 (2010).
Lukianova-Hleb, E.Y. et al. Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems. PLoS ONE 7, e34537 (2012).
Lukianova-Hleb, E.Y., Ren, X., Zasadzinski, J.A., Wu, X. & Lapotko, D. Plasmonic nanobubbles enhance efficacy and selectivity of chemotherapy against drug-resistant cancer cells. Adv. Mater. 24, 3831–3837 (2012).
Koukourakis, M.I. et al. Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. J. Clin. Oncol. 17, 3512–3521 (1999).
Torchilin, V.P., Lukyanov, A.N., Gao, Z. & Papahadjopoulos-Sternberg, B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. USA 100, 6039–6044 (2003).
Wagner, D.S. et al. The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts. Biomaterials 31, 7567–7574 (2010).
Hainfeld, J.F. et al. Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys. Med. Biol. 55, 3045–3059 (2010).
Hainfeld, J.F., Slatkin, D.N. & Smilowitz, H.M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 49, N309–N315 (2004).
Calais, G. et al. Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy. Bull. Cancer 87, 48–53 (2000).
Sano, D. et al. Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro. Clin. Cancer Res. 17, 1815–1827 (2011).
Sano, D. et al. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clin. Cancer Res. 17, 6658–6670 (2011).
Lukianova-Hleb, E.Y., Volkov, A.N., Wu, X. & Lapotko, D.O. Transient enhancement and spectral narrowing of the photothermal effect of plasmonic nanoparticles under pulsed excitation. Adv. Mater. 25, 772–776 (2013).
Welch, A.J. & van Gemert, M.J.C. in Optical-Thermal Response of Laser-Irradiated Tissue 2nd edn. (eds. Welch, A.J. & van Gemert, M.J.C.) 3–11 (Springer, 2011).
Ambrosch, P. The role of laser microsurgery in the treatment of laryngeal cancer. Curr. Opin. Otolaryngol. Head Neck Surg. 15, 82–88 (2007).
Karni, R.J., Rich, J.T., Sinha, P. & Haughey, B.H. Transoral laser microsurgery: a new approach for unknown primaries of the head and neck. Laryngoscope 121, 1194–1201 (2011).
Lukianova-Hleb, E.Y. & Lapotko, D. Influence of transient environmental photothermal effects on optical scattering by gold nanoparticles. Nano Lett. 9, 2160–2166 (2009).
Rahman, W.N. et al. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine 5, 136–142 (2009).
Jiao, P. et al. Leading neuroblastoma cells to die by multiple premeditated attacks from a multifunctionalized nanoconstruct. J. Am. Chem. Soc. 133, 13918–13921 (2011).
Argiris, A., Karamouzis, M.V., Raben, D. & Ferris, R.L. Head and neck cancer. Lancet 371, 1695–1709 (2008).
Jegannathen, A. et al. Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study. Clin. Oncol. (R Coll Radiol) 23, 149–158 (2011).
Chen, Y. et al. Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy a therapeutic approach on the basis of preclinical research of human cancer cell lines. Clin. Cancer Res. 9, 969–975 (2003).
Paliwal, S. & Mitragotri, S. Ultrasound-induced cavitation: applications in drug and gene delivery. Expert Opin. Drug Deliv. 3, 713–726 (2006).
Czarnota, G.J. et al. Tumor radiation response enhancement by acoustical stimulation of the vasculature. Proc. Natl. Acad. Sci. USA 109, E2033–E2041 (2012).
Rapoport, N. et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J. Control. Release 153, 4–15 (2011).
Gao, Z., Kennedy, A.M., Christensen, D.A. & Rapoport, N.Y. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 48, 260–270 (2008).
Rapoport, N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog. Polym. Sci. 32, 962–990 (2007).
Rapoport, N.Y., Gao, Z., Kamaev, P. & Christensen, D.A. Ultrasound-enhanced localized chemotherapy of drug-sensitive and multidrug resistant tumors. AIP Conf. Proc. 829, 481 (2006).
Allen, T.M. & Cullis, P.R. Drug delivery systems: entering the mainstream. Science 303, 1818–1822 (2004).
Schroeder, A. et al. Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer 12, 39–50 (2011).
Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751–760 (2007).
de Carvalho, A.C. et al. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients. Oral Oncol. 48, 240–248 (2012).
Zhang, H.F., Maslov, K., Stoica, G. & Wang, L.V. Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging. Nat. Biotechnol. 24, 848–851 (2006).
Qian, X. et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 26, 83–90 (2008).
Merchant, B. Gold, the noble metal and the paradoxes of its toxicology. Biologicals 26, 49–59 (1998).
Root, S.W., Andrews, G.A., Kniseley, R.M. & Tyor, M.P. The distribution and radiation effects of intravenously administered colloidal gold-198 in man. Cancer 7, 856–866 (1954).
Lapotko, D.O., Lukianova-Hleb, E. & Oraevsky, A. Clusterization of nanoparticles during their interaction with living cells. Nanomedicine 2, 241–253 (2007).
Weissleder, R. A clearer vision for in vivo imaging. Nat. Biotechnol. 19, 316–317 (2001).
Qian, X. et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 26, 83–90 (2008).
Vogl, T.J., Naguib, N.N., Lehnert, T. & Nour-Eldin, N.E. Radiofrequency, microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations–review article. Eur. J. Radiol. 77, 346–357 (2011).
O'Neal, D.P., Hirsch, L.R., Halas, N.J., Payne, J.D. & West, J.L. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 209, 171–176 (2004).
Roedel, R.M. et al. Transoral laser microsurgery for recurrence after primary radiotherapy of early glottic cancer. Auris Nasus Larynx 37, 474–481 (2010).
Agarwal, A., MacKey, M.A., El-Sayed, M.A. & Bellamkonda, R.V. Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano 5, 4919–4926 (2011).
Braun, G.B. et al. Laser-activated gene silencing via gold nanoshell-siRNA conjugates. ACS Nano 3, 2007–2015 (2009).
Park, J.H. et al. Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv. Mater. 22, 880–885 (2010).
O'Neill, B.E. & Rapoport, N. Phase-shift, stimuli-responsive drug carriers for targeted drug delivery. Ther. Deliv. 2, 1165–1187 (2011).
Rapoport, N., Gao, Z. & Kennedy, A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J. Natl. Cancer Inst. 99, 1095–1106 (2007).
Panyam, J. & Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329–347 (2003).
Kamaly, N. et al. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem. Soc. Rev. 41, 2971–3010 (2012).
Qiu, Y. & Park, K. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev. 53, 321–339 (2001).
Ferrara, K.W. Driving delivery vehicles with ultrasound. Adv. Drug Deliv. Rev. 60, 1097–1102 (2008).
Rapoport, N.Y., Kennedy, A.M., Shea, J.E., Scaife, C.L. & Nam, K.H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J. Control. Release 138, 268–276 (2009).
Kennedy, J.E. High-intensity focused ultrasound in the treatment of solid tumours. Nat. Rev. Cancer 5, 321–327 (2005).
Acknowledgements
We thank J. Myers (MD Anderson Cancer Center, NOM9 cell line), L. Metelitsa (Texas Children's Hospital, J32 cell line) and J. Ensley (Wayne State University, HN30 and HN31 cell lines) for sharing cell lines, E. Hanna, A. Gillenwater, H. Skinner and M. Kupferman for helpful discussions of head and neck cancer, G. Peng, R. Bouchard and C. Kingsley for technical help, D.S. Wagner for discussing cellular effects of PNBs, G. Mixon, S. Saunders, D. Grayson and M. Martinez for engineering and administrative help, D. Townley for performing transmission electron microscopy and W. Hartner and S. Parminter for editing. This work was supported by US National Institutes of Health (NIH) grant R01GM094816, US National Science Foundation grant CBET-1341212 and Virginia and L.E. Simmons Family Foundation Award (D.O.L.), US NIH grants R01CA128486 (V.P.T.), 5U54151881-012 (V.P.T.) and S10RR026399-01 (confocal microscope).
Author information
Authors and Affiliations
Contributions
E.Y.L.-H.,V.P.T. and D.O.L. discussed the results and wrote the paper; D.O.L. conceived the strategy and designed the experiments; E.Y.L.-H. and D.O.L. performed the experiments; E.Y.L.-H., V.P.T., X.W. and D.O.L. analyzed the data; R.R.S. prepared nanocarriers; and X.W. and X.R. prepared and analyzed the animals.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–6, Supplementary Methods and Supplementary Table 1 (PDF 1444 kb)
Rights and permissions
About this article
Cite this article
Lukianova-Hleb, E., Ren, X., Sawant, R. et al. On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles. Nat Med 20, 778–784 (2014). https://doi.org/10.1038/nm.3484
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3484
This article is cited by
-
Plasmonics for neuroengineering
Communications Materials (2023)
-
Assessment of sub-200-nm nanobubbles with ultra-high stability in water
Applied Water Science (2023)
-
Digital plasmonic nanobubble detection for rapid and ultrasensitive virus diagnostics
Nature Communications (2022)
-
Metasurface-based multi-harmonic free-electron light source
Light: Science & Applications (2018)
-
Light in diagnosis, therapy and surgery
Nature Biomedical Engineering (2017)